Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Survey report: How CROs use real-world data and lab insights to improve clinical trials

Survey report

Patient recruitment is the #1 challenge in clinical trials, with 59% of executives calling it the hardest part of the process and 85% struggling to find eligible patients. While 82% of CROs plan to increase their use of real-world data (RWD), success hinges on using the right data.

 

Our new report, based on a survey of 150 clinical trial leaders, reveals why lab data is the most frequently used RWD source (61%) and holds the key to solving today’s toughest recruitment challenges.

 

Download the report to learn how to turn recruitment into your competitive advantage.

Survey report: How CROs use RWD and lab insights to improve clinical trials

See the value of using RWD and lab insights to improve clinical trials

938

* indicates required

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.